Adelon Side Effects

Glaucoma with optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infections from pathogens including herpes simplex and fungi, and perforation of the globe.
Rarely, filtering blebs have been reported when topical steroids have been used following cataract surgery.
Rarely, stinging or burning may occur.
Very rare (<1/10000): Very rare cases of coronary catheterisation have been reported in patients with significantly damaged corneas in combination with the use of phosphate-containing ophthalmic drops.
Not Known (frequency cannot be estimated from available data): Immune system disorders: Hypersensitivity, usually of a delayed type, which can lead to irritation, burning, tingling and itching.
Nervous system disorders: Headache.
Skin and subcutaneous tissue disorders: Dermatitis, itching, rash.
Eye disorders: Topical administration of corticosteroids may result in elevated intraocular pressure which can lead to optic nerve damage, reduced visual acuity and visual field defects. Other side effects are chorioretinopathy, mydriasis, ptosis, epithelial punctate keratitis and possible softening of the cornea or sclera. Within a few days after discontinuation of topical ophthalmic corticosteroids and occasionally during treatment, acute anterior uveitis without pre-existing ocular inflammation or infection has occurred in patients (mostly Black patients).
Intensive or prolonged use of topical corticosteroids may lead to formation of posterior subcapsular cataracts.
In those diseases causing thinning of the cornea or sclera, corticosteroid therapy may result in thinning of the globe leading to perforation.
Vision blurred.
Foreign body sensation.
Gastrointestinal disorders: Dysgeusia.